Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis

Lien vers Pubmed [PMID] – 20061921

Transplantation 2010 Jan;89(1):69-74

Cerebrospinal fluid (CSF) analysis is often deferred in patients with cryptococcal disease, particularly in the absence of neurologic manifestations. We sought to determine whether a subset of solid organ transplant (SOT) recipients with high likelihood of central nervous system (CNS) disease could be identified in whom CSF analysis must be performed.